Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dexiang Gao

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 31, 2014
Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinomaElaine T Lam, Michael K K Wong, Neeraj Agarwal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2018
Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation TherapyYevgeniy Vinogradskiy, Chad G Rusthoven, Leah Schubert, et al.
Journal of the American Chemical Society|April 21, 2025
Ordered Graphane Nanoribbons Synthesized via High-Pressure Diels-Alder Polymerization of 2,2'-BipyrazineFang Li, Xingyu Tang, Yunfan Fei, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expressionShengxiang Ren, Qinrui Tian, Nadav Amar, et al.
Clinical Lung Cancer|August 28, 2018
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell LinesShengxiang Ren, Christopher J Rivard, Hui Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
A single arm phase 2 trial of doxorubicin plus zalifrelimab (anti-CTLA-4 antibody) and balstilimab (anti-PD-1 antibody) in advanced/metastatic soft tissue sarcomasBreelyn A Wilky, Katherine A Julian, Alessandra Maleddu, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 3, 2022
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic driversSamantha M Y Chen, Vince Popolizio, Rachel A Woolaver, et al.
Oral Oncology|December 26, 2015
A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinomaDaniel W Bowles, Stephen B Keysar, Justin R Eagles, et al.
Nano Letters|January 10, 2025
High-Pressure Polymerization of Phenol toward Degree-4 Carbon NanothreadXin Yang, Guangwei Che, Yajie Wang, et al.
The Journal of Physical Chemistry Letters|December 14, 2021
Crystalline Fully Carboxylated Polyacetylene Obtained under High Pressure as a Li-Ion Battery Anode MaterialXuan Wang, Xingyu Tang, Peijie Zhang, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 31, 2014
Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinomaElaine T Lam, Michael K K Wong, Neeraj Agarwal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2018
Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation TherapyYevgeniy Vinogradskiy, Chad G Rusthoven, Leah Schubert, et al.
Journal of the American Chemical Society|April 21, 2025
Ordered Graphane Nanoribbons Synthesized via High-Pressure Diels-Alder Polymerization of 2,2'-BipyrazineFang Li, Xingyu Tang, Yunfan Fei, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expressionShengxiang Ren, Qinrui Tian, Nadav Amar, et al.
Clinical Lung Cancer|August 28, 2018
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell LinesShengxiang Ren, Christopher J Rivard, Hui Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
A single arm phase 2 trial of doxorubicin plus zalifrelimab (anti-CTLA-4 antibody) and balstilimab (anti-PD-1 antibody) in advanced/metastatic soft tissue sarcomasBreelyn A Wilky, Katherine A Julian, Alessandra Maleddu, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 3, 2022
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic driversSamantha M Y Chen, Vince Popolizio, Rachel A Woolaver, et al.
Oral Oncology|December 26, 2015
A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinomaDaniel W Bowles, Stephen B Keysar, Justin R Eagles, et al.
Nano Letters|January 10, 2025
High-Pressure Polymerization of Phenol toward Degree-4 Carbon NanothreadXin Yang, Guangwei Che, Yajie Wang, et al.
The Journal of Physical Chemistry Letters|December 14, 2021
Crystalline Fully Carboxylated Polyacetylene Obtained under High Pressure as a Li-Ion Battery Anode MaterialXuan Wang, Xingyu Tang, Peijie Zhang, et al.
Pageof 17